Corporate
  • UCB

    Created in 1928
  • Social networks

    11,166 20,115 1,808 254,916
  • Location

    All. de la Recherche 60, 1070 Anderlecht, Belgium

    Anderlecht

    Belgium

  • Engaged entities

    233
    173 56
  • Added in Motherbase

    2 Aug 2022, 2:41 p.m.
Description
  • Value proposition

    Inspired by patients. Driven by science.

    UCB – Inspired by patients. Driven by science. At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talents makes the most of who they are, unlocking innovation and setting new standards for patients.

    Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?”
    And to find the answers, we connect globally with patients and their families living with the physical and social burdens of severe disease. These connections give us new perspectives, drive our innovation, and offer a hope for a new generation of therapies that will help to transform lives.

    UCB – The Facts

    With approximately 9000 employees in around 40 countries, we are a global biopharmaceutical company headquartered in Brussels, Belgium which invests more than 25% of revenue in cutting-edge scientific research to meet unmet patient needs.
    A few other reasons that make UCB an amazing place to work:
    - Promising pipeline that includes several novel molecules;
    - 2023 Key Financials: € 5.3 billion global revenue

    Specialties: Neurology, Immunology

    Neurology, Immunology, and Healthcare Innovation Beyond Medicine

Entity interactions BETA
Entity TypeTweets Articles
Hack Belgium Labs Hack Belgium Labs
Events Services, it services
Other

30 May 2022

13 May 2024



International Osteoporosis Foundation International Osteoporosis Foundation
entertainment, Wellness and Fitness Services
Other

21 Oct 2022


Vivactis Weber Vivactis Weber
healthtech, Research Services
Other

31 Oct 2022


Radars
Loading...